Daniel Schefer currently serves as Laboratory Manager at Envisagenics since June 2025, following a role as Research Associate at Inspirna, Inc. from November 2022 to March 2025, where contributions included the validation of new drug targets and the development of novel therapeutics, specifically focusing on SLC6A8 and MerTK. Prior experience includes research positions at Washington University School of Medicine, where work on Malignant Peripheral Nerve Sheath Tumor Patient Derived Xenografts was conducted, and at the Herbert Irving Comprehensive Cancer Center under Dr. Laura Pasqualucci, investigating B-Cell cancer pathogenesis. Daniel holds a Bachelor's degree in Biochemistry and Molecular Biology from Washington University in St. Louis, earned in 2022.
This person is not in the org chart
This person is not in any teams
This person is not in any offices